Clinical Director of the National Institute of Drug Abuse Dr. Lorenzo Leggio, said GLP-1 drugs' effect on the brain can help ...
ZME Science on MSN
Smart Drug Shrinks Tumors in Cancer Patients With No Options Left
“Amivantamab is a ‘smart’ drug that not only blocks two key cancer pathways but also helps the immune system do its job,” ...
The Healthy @Reader's Digest on MSN
My Doctor Heard Something Strange in My Voice—Then Diagnosed Me with This Autoimmune Disease
This rare autoimmune disease affects tens of thousands of Americans. A Texas farmer shares his journey to addressing it.
Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...
Equity Insider News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. 17, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – MIT and ...
Baystreet.ca News Commentary – Scientists engineered invisible immune cells in October 2025 that hide from rejection while destroying tumors[1], as antibody drug conjugates expanded ...
Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...
Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today provided preliminary revenue and financial results for the quarter ...
Biomarker-driven drug development accelerates across oncology as companies advance novel mechanisms targeting previously ...
Biomarker-driven approaches enhance the likelihood of identifying optimal patient populations and streamline trials through accelerated approval pathways, with FDA approvals incorporating increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback